申请人:Heer Jag Paul
公开号:US20130072499A1
公开(公告)日:2013-03-21
The present invention relates to novel piperazine compounds; to pharmaceutical compositions containing the compounds; and to the use of the compounds in therapy to treat diseases for which blocking the Ca
v
2.2 calcium channels is beneficial and to treat diseases for which blocking the Ca
v
2.2 and Ca
v
3.2 calcium channels is beneficial, e.g. to treat pain.
本发明涉及新型哌嗪化合物;含有这些化合物的药物组合物;以及利用这些化合物在治疗中治疗阻断Ca
v
2.2钙通道有益的疾病,以及治疗阻断Ca
v
2.2和Ca
v
3.2钙通道有益的疾病,例如治疗疼痛。